LP34967-7

ARIPiprazole

Active

Description

Aripiprazole (brand name Abilify) is in the atypical antipsychotics drug class and used to treat the symptoms of schizophrenia in adults and teenagers. Other uses include; treatment for episodes of mania or mixed episodes in adults, teenagers, and children 10 years of age and older with bipolar disorder, as an antidepressant to treat depression when symptoms cannot be controlled by the antidepressant alone, and to treat children 6 to 17 years of age who have autistic disorder. Aripiprazole is not approved by the Food and Drug Administration (FDA) for the treatment in older adults with dementia as there is an increased chance of stroke or death during treatment. Use is associated with hyperglycemia. Source: Regenstrief LOINC , Medlineplus: a603012

Basic Part Properties

Part Name

ARIPiprazole

Part Display Name

ARIPiprazole

Part Type

Component (Describes the core component or analyte measured)

Created On

2005-01-03

Construct for LOINC Short Name

ARIPiprazole

Related Codes

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.

CodeSystem lookup

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP34967-7

ConceptMap translate

https://fhir.loinc.org/ConceptMap/$translate?system=http://loinc.org&code=LP34967-7

Language Variants Get Info

LOINC Copyright

Copyright © 2025 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.